Quality of life and pruritus over 52 weeks of apremilast treatment in biologic-naive patients with moderate plaque psoriasis: Results of a real-world, multicenter, prospective study in Greece (APRAISAL)

被引：0
|
作者：
Ioannides, Dimitrios [1 ,2 ]
Tampouratzi, Eleftheria [3 ]
Rigopoulos, Dimitrios [4 ]
Drosos, Alexandros [5 ]
Rovithi, Evangelia [6 ]
Papadavid, Evangelia [7 ]
Papageorgiou, Marina [8 ]
Bassukas, Ioannis [9 ]
Zafiriou, Efterpi [10 ]
Panagakis, Pantelis [11 ]
机构：
[1] Aristotle Univ Thessaloniki, Univ Dept Dermatol 1, Thessaloniki, Greece
[2] Hosp Venereal Skin Dis Thessaloniki, Thessaloniki, Greece
[3] Piraeus Reg Gen Hosp Tzaneio, Dermatol Unit, Piraeus, Greece
[4] Natl Kapodistrian Univ Athens, Dept Dermatol & Venereol 1, Athens, Greece
[5] Gen Hosp Xanthi, Dept Dermatol, Athens, Greece
[6] Venizeleio Pananeio Gen Hosp Heraklion, Dept Dermatol & Venereol, Iraklion, Greece
[7] Natl Kapodistrian Univ Athens, Attikon Univ Gen Hosp, Dept Dermatol & Venereol 2, Athens, Greece
[8] Hosp Venereal & Skin Dis Thessaloniki, State Dept Dermatol, Thessaloniki, Greece
[9] Univ Ioannina, Dept Skin & Venereal Dis, Ioannina, Greece
[10] Univ Gen Hosp Larissa, Univ Clin Dermatol, Larisa, Greece
[11] Andreas Sygros Hosp Athens, Dermatol & Venereol Dept NHS, Athens, Greece
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27506
引用
收藏
页码：AB150 / AB150
页数：1
相关论文
共 50 条
  • [1] Effect of apremilast on quality of life, pruritus, and psoriasis in special areas after 52 weeks of therapy in biologic-naive patients with moderate plaque psoriasis who did not achieve a PASI-75 response: Real-world, prospective study in Greece -APRAISAL
    Papakonstantis, Markos
    Lazaridou, Elizabeth
    Neofotistou, Ourania
    Anastasiadis, Georgios
    Kalinou, Christina
    Aronis, Panteleimon
    Protopapa, Anastasia
    Lefaki, Ioanna
    Krasagakis, Konstantinos
    Spiliopoulos, Theofanis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB148 - AB148
  • [2] Improvement in specific locations, quality of life, and pruritus after 24 weeks of apremilast in bio-naive moderate plaque psoriasis patients who failed to achieve a PASI-75 response: Interim results of a real-world prospective study in Greece (APRAISAL)
    Ioannides, Dimitrios
    Vryzaki, Eleftheria
    Pantelis, Panagakis
    Panagakis, Pantelis
    Syggros, Andreas
    Tampouratzi, Eleftheria
    Drosos, Alexandros
    Dimitris, Rigopoulos
    Rigopoulos, Dimitris
    Antoniou, Christina
    Tomai, Kalliopi
    Bassukas, Ioannis
    Papakonstantis, Markos
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB10 - AB10
  • [3] Effectiveness and safety of apremilast in biologic-naive patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study
    Ioannides, D.
    Antonakopoulos, N.
    Georgiou, S.
    Chasapi, V
    Katsantonis, I
    Drosos, A.
    Rigopoulos, D.
    Antoniou, C.
    Anastasiadis, G.
    Bassukas, I
    Ioannidou, D.
    Protopapa, A.
    Neofotistou, O.
    Krasagakis, K.
    Aronis, P.
    Papageorgiou, M.
    Lazaridou, E.
    Patsatsi, A.
    Lefaki, I
    Roussaki-Schulze, A., V
    Satra, F.
    Anagnostopoulos, Z.
    Papakonstantis, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (09) : 1838 - 1848
  • [4] Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL
    Gold, Linda Stein
    Bagel, Jerry
    Lebwohl, Mark
    Jackson, J. Mark
    Chen, Rongdean
    Goncalves, Joana
    Levi, Eugenia
    Duffin, Kristina Collis
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (02) : 221 - 228
  • [5] A real-world, non-interventional, prospective study of the effectiveness and safety of apremilast in bio-naive adults with moderate plaque psoriasis treated in the routine care in Greece - the 'APRAISAL' study
    Ioannides, D.
    Antonakopoulos, N.
    Chasapi, V
    Oikonomou, C.
    Tampouratzi, E.
    Lazaridou, E.
    Rigopoulos, D.
    Neofotistou, O.
    Drosos, A.
    Anastasiadis, G.
    Rovithi, E.
    Kalinou, C.
    Papadavid, E.
    Aronis, P.
    Papageorgiou, M.
    Protopapa, A.
    Bassukas, I
    Lefaki, I
    Zafiriou, E.
    Krasagakis, K.
    Pokas, E.
    Anagnostopoulos, Z.
    Kekki, A.
    Papakonstantis, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) : 2055 - 2063
  • [6] Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (01) : 45 - 54
  • [7] Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (04) : 365 - 371
  • [8] Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    Khilfeh, Ibrahim
    Curtis, Jeffrey R.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (11) : 767 - 779
  • [9] REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    VALUE IN HEALTH, 2019, 22 : S888 - S888
  • [10] Real-world efficacy of apremilast in patients with moderate plaque psoriasis: Results from the Corrona Psoriasis Registry
    Merola, Joseph
    Gottlieb, Alice B.
    McLean, Robert R.
    Cirulli, Joshua
    Williams, Catherine
    Linowski, Gregory
    Litman, Heather J.
    Guo, Ning
    Emeanuru, Kelechi
    Strober, Bruce
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB115 - AB115
12345